Remission of type 2 diabetes: underlying mechanisms revealed by the Diabetes Remission Clinical Trial (DiRECT) - Media Centre | EASD
2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial - The Lancet Diabetes & Endocrinology
The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial | BMC Primary Care | Full Text
Overview of the Project - DIRECT
Direct Trial
Lifestyle Interventions for Type 2 Diabetes Remission - Beyond Type 2
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial - The Lancet
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial - The Lancet Diabetes & Endocrinology
Diabetes remission study DiRECT reviewed with an update on global roll-out of remission programmes – TDMR
Lifestyle Interventions for Type 2 Diabetes Remission - Beyond Type 2
DiRECT (Diabetes Remission Clinical Trial) - ppt download
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme | SpringerLink
New DiRECT study uncovers the science behind remission | Diabetes UK
The latest findings from DiRECT | Diabetes UK
Modelling the rate of deterioration of diabetes in observational data: a DIRECT study - Media Centre | EASD
NHS to pilot remission clinics - Raconteur
Diabetes UK announce 'DIRECT' trial results after Year 1 - Diabetes Ireland : Diabetes Ireland
Typ-2-Diabetes | Zweijahresergebnisse der DiRECT-Studie (Diabetes Remission Clinical Trial) | springermedizin.de
Counterweight - Impressive, right? We think so too. Our programme has been tested by the largest Diabetes remission clinical trial in the UK, the DiRECT study. The results of the study showed
Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial - The Lancet
Reversing Type 2 Diabetes is Possible – Results From the DiRECT Trial: The Alpine Center for Diabetes, Endocrinology, and Metabolism, PC: Endocrinology
